Biodexa Pharmaceuticals PLC (BDRX)
5.68
-0.23
(-3.89%)
USD |
NASDAQ |
Nov 04, 16:00
5.68
0.00 (0.00%)
After-Hours: 20:00
Biodexa Pharmaceuticals Accrued Comprehensive Inc (Quarterly)
Accrued Comprehensive Inc (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Accrued Comprehensive Inc (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -- |
| June 30, 2024 | -- |
| December 31, 2023 | -- |
| June 30, 2023 | -- |
| June 30, 2023 | -- |
| December 31, 2022 | -- |
| June 30, 2022 | -- |
| June 30, 2022 | -- |
| December 31, 2021 | -- |
| June 30, 2021 | -- |
| June 30, 2021 | -- |
| December 31, 2020 | -- |
| June 30, 2020 | -- |
| Date | Value |
|---|---|
| June 30, 2020 | -- |
| December 31, 2019 | -- |
| June 30, 2019 | -- |
| June 30, 2019 | -- |
| December 31, 2018 | -- |
| June 30, 2018 | -- |
| June 30, 2018 | -- |
| December 31, 2017 | -- |
| June 30, 2017 | -- |
| June 30, 2017 | -- |
| December 31, 2016 | -- |
| June 30, 2016 | -- |
| June 30, 2016 | -- |
Comprehensive Income Definition
Comprehensive Income is the sum of Net Income and other income statement items gains/losses that have not been realized. This may include items such as unrealized gains/losses on securities / transactions or foreign currency gains / losses. Comprehensive Income may be reported in a separate statement called Owners Change in Equity.